Vascular differentiation from embryonic stem cells: Novel technologies and therapeutic promises

Vascular Pharmacology

Volumn 56, Issue 5-6, 2012, Pages 267-279

  Descamps, Betty ^a   Emanueli, Costanza ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Angiogenesis; Embryonic stem cells; Ischemia; Vascular differentiations; Vasculogenesis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BONE MORPHOGENETIC PROTEIN 4; CALDESMON; CALMODULIN; CALPONIN; CD31 ANTIGEN; CD34 ANTIGEN; DESMIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; GELATIN; LEUKEMIA INHIBITORY FACTOR; MYOSIN HEAVY CHAIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN TYROSINE KINASE; PROTEOCHONDROITIN SULFATE; RGS PROTEIN; SMOOTHELIN; STAGE SPECIFIC EMBRYO ANTIGEN 1; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BLASTOCYST; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL POPULATION; CELL SELECTION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HEMANGIOBLAST; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIC HEART DISEASE; MESODERM; MORPHOGENESIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERICYTE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REGENERATION; REVIEW; TISSUE REPAIR; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CYTOLOGY; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATIVE MEDICINE; TRANSPLANTATION;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; REGENERATIVE MEDICINE;

EID: 84866175595     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.03.007     Document Type: Review

References (146)

1. Albinsson S., Suarez Y., Skoura A., Offermanns S., Miano J.M., Sessa W.C. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1118-1126.
2. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circ. Res. 2005, 97:512-523.
3. Banerjee S., Bacanamwo M. DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells. Exp. Cell Res. 2010, 316:172-180.
4. Barroso-del Jesus A., Lucena-Aguilar G., Menendez P. The miR-302-367 cluster as a potential stemness regulator in ESCs. Cell Cycle 2009, 8:394-398.
5. Beddington R.S., Rashbass P., Wilson V. Brachyury-a gene affecting mouse gastrulation and early organogenesis. Dev. Suppl. 1992, 157-165.
6. Bergers G., Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro-oncology 2005, 7:452-464.
7. Blancas A.A., Lauer N.E., McCloskey K.E. Endothelial differentiation of embryonic stem cells. Curr. Protoc. Stem Cell Biol. 2008, Chapter 1, Unit 1F 5.
8. Blancas A.A., Shih A.J., Lauer N.E., McCloskey K.E. Endothelial cells from embryonic stem cells in a chemically defined medium. Stem Cells Dev. 2011, 12:2153-2161.
9. Brinster R.L. The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med. 1974, 140:1049-1056.
10. Burdsal C.A., Damsky C.H., Pedersen R.A. The role of E-cadherin and integrins in mesoderm differentiation and migration at the mammalian primitive streak. Development 1993, 118:829-844.
11. Caporali A., Emanueli C. MicroRNA regulation in angiogenesis. Vascul. Pharmacol. 2011, 55:79-86.
12. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
13. Chadwick K., Wang L., Li L., Menendez P., Murdoch B., Rouleau A., Bhatia M. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003, 102:906-915.
14. Chen S.S., Fitzgerald W., Zimmerberg J., Kleinman H.K., Margolis L. Cell-cell and cell-extracellular matrix interactions regulate embryonic stem cell differentiation. Stem Cells 2007, 25:553-561.
15. Chen T., Bai H., Shao Y., Arzigian M., Janzen V., Attar E., Xie Y., Scadden D.T., Wang Z.Z. Stromal cell-derived factor-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro. Stem Cells 2007, 25:392-401.
16. Cheung C., Sinha S. Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation. J. Mol. Cell. Cardiol. 2011, 51:651-664.
17. Chiang P.M., Wong P.C. Differentiation of an embryonic stem cell to hemogenic endothelium by defined factors: essential role of bone morphogenetic protein 4. Development 2011, 138:2833-2843.
18. Chicha L., Feki A., Boni A., Irion O., Hovatta O., Jaconi M. Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics. PLoS One 2011, 6:e14733.
19. Cho S.W., Moon S.H., Lee S.H., Kang S.W., Kim J., Lim J.M., Kim H.S., Kim B.S., Chung H.M. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007, 116:2409-2419.
20. Christoforou N., Oskouei B.N., Esteso P., Hill C.M., Zimmet J.M., Bian W., Bursac N., Leong K.W., Hare J.M., Gearhart J.D. Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. PLoS One 2010, 5:e11536.
21. Cimato T., Beers J., Ding S., Ma M., McCoy J.P., Boehm M., Nabel E.G. Neuropilin-1 identifies endothelial precursors in human and murine embryonic stem cells before CD34 expression. Circulation 2009, 119:2170-2178.
22. Cleaver O., Melton D.A. Endothelial signaling during development. Nat. Med. 2003, 9:661-668.
23. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., Lee T.H., Miano J.M., Ivey K.N., Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
24. Coultas L., Chawengsaksophak K., Rossant J. Endothelial cells and VEGF in vascular development. Nature 2005, 438:937-945.
25. Cumano A., Godin I. Ontogeny of the hematopoietic system. Annu. Rev. Immunol. 2007, 25:745-785.
26. Davis R.P., Ng E.S., Costa M., Mossman A.K., Sourris K., Elefanty A.G., Stanley E.G. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 2008, 111:1876-1884.
27. Diaz-Flores L., Gutierrez R., Lopez-Alonso A., Gonzalez R., Varela H. Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis. Clin. Orthop. Relat. Res. 1992, 280-286.
28. Doetschman T.C., Eistetter H., Katz M., Schmidt W., Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 1985, 87:27-45.
29. Doss M.X., Gaspar J.A., Winkler J., Hescheler J., Schulz H., Sachinidis A. Specific gene signatures and pathways in mesodermal cells and their derivatives derived from embryonic stem cells. Stem Cell Rev. 2012, 1:43-54.
30. Ema M., Yokomizo T., Wakamatsu A., Terunuma T., Yamamoto M., Takahashi S. Primitive erythropoiesis from mesodermal precursors expressing VE-cadherin, PECAM-1, Tie2, endoglin, and CD34 in the mouse embryo. Blood 2006, 108:4018-4024.
31. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
32. Fasanaro P., D'Alessandra Y., Di Stefano V., Melchionna R., Romani S., Pompilio G., Capogrossi M.C., Martelli F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 2008, 283:15878-15883.
33. Fehling H.J., Lacaud G., Kubo A., Kennedy M., Robertson S., Keller G., Kouskoff V. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 2003, 130:4217-4227.
34. Flamme I., Frolich T., Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell. Physiol. 1997, 173:206-210.
35. Fraser S.T., Hadjantonakis A.K., Sahr K.E., Willey S., Kelly O.G., Jones E.A., Dickinson M.E., Baron M.H. Using a histone yellow fluorescent protein fusion for tagging and tracking endothelial cells in ES cells and mice. Genesis 2005, 42:162-171.
36. Ginis I., Luo Y., Miura T., Thies S., Brandenberger R., Gerecht-Nir S., Amit M., Hoke A., Carpenter M.K., Itskovitz-Eldor J., et al. Differences between human and mouse embryonic stem cells. Dev. Biol. 2004, 269:360-380.
37. Goldman O., Feraud O., Boyer-Di Ponio J., Driancourt C., Clay D., Le Bousse-Kerdiles M.C., Bennaceur-Griscelli A., Uzan G. A boost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage. Stem Cells 2009, 27:1750-1759.
38. Gonzalez F., Boue S., Izpisua Belmonte J.C. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat. Rev. Genet. 2011, 12:231-242.
39. Hall A.P. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy. Toxicol. Pathol. 2006, 34:763-775.
40. Han Y., Kuang S.Z., Gomer A., Ramirez-Bergeron D.L. Hypoxia influences the vascular expansion and differentiation of embryonic stem cell cultures through the temporal expression of vascular endothelial growth factor receptors in an ARNT-dependent manner. Stem Cells 2010, 28:799-809.
41. Han Y., Li N., Tian X., Kang J., Yan C., Qi Y. Endogenous transforming growth factor (TGF) beta1 promotes differentiation of smooth muscle cells from embryonic stem cells: stable plasmid-based siRNA silencing of TGF beta1 gene expression. J. Physiol. Sci. 2010, 60:35-41.
42. Hanjaya-Putra D., Gerecht S. Vascular engineering using human embryonic stem cells. Biotechnol. Prog. 2009, 25:2-9.
43. Harb N., Archer T.K., Sato N. The Rho-Rock-Myosin signaling axis determines cell-cell integrity of self-renewing pluripotent stem cells. PLoS One 2008, 3:e3001.
44. Hellstrom M., Kalen M., Lindahl P., Abramsson A., Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047-3055.
45. Hill K.L., Obrtlikova P., Alvarez D.F., King J.A., Keirstead S.A., Allred J.R., Kaufman D.S. Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. Exp. Hematol. 2010, 38(246-257):e241.
46. Howard L., Kane N.M., Milligan G., Baker A.H. MicroRNAs regulating cell pluripotency and vascular differentiation. Vascul. Pharmacol. 2011, 4:69-78.
47. Huang H., Nakayama Y., Qin K., Yamamoto K., Ando J., Yamashita J., Itoh H., Kanda K., Yaku H., Okamoto Y., et al. Differentiation from embryonic stem cells to vascular wall cells under in vitro pulsatile flow loading. J. Artif. Organs 2005, 8:110-118.
48. Huang H., Zhao X., Chen L., Xu C., Yao X., Lu Y., Dai L., Zhang M. Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochem. Biophys. Res. Commun. 2006, 351:321-327.
49. Huang H., Xie C., Sun X., Ritchie R.P., Zhang J., Chen Y.E. miR-10a contributes to retinoid acid-induced smooth muscle cell differentiation. J. Biol. Chem. 2010, 285:9383-9389.
50. Huang N.F., Niiyama H., Peter C., De A., Natkunam Y., Fleissner F., Li Z., Rollins M.D., Wu J.C., Gambhir S.S., et al. Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler. Thromb. Vasc. Biol. 2010, 30:984-991.
51. Jakobsson L., Kreuger J., Holmborn K., Lundin L., Eriksson I., Kjellen L., Claesson-Welsh L. Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev. Cell 2006, 10:625-634.
52. Jakobsson L., Kreuger J., Claesson-Welsh L. Building blood vessels-stem cell models in vascular biology. J. Cell Biol. 2007, 177:751-755.
53. James D., Nam H.S., Seandel M., Nolan D., Janovitz T., Tomishima M., Studer L., Lee G., Lyden D., Benezra R., et al. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nat. Biotechnol. 2010, 28:161-166.
54. Jin S.W., Patterson C. The opening act: vasculogenesis and the origins of circulation. Arterioscler. Thromb. Vasc. Biol. 2009, 29:623-629.
55. Judson R.L., Babiarz J.E., Venere M., Blelloch R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat. Biotechnol. 2009, 27:459-461.
56. Kane N.M., Meloni M., Spencer H.L., Craig M.A., Strehl R., Milligan G., Houslay M.D., Mountford J.C., Emanueli C., Baker A.H. Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1389-1397.
57. Kane N.M., Xiao Q., Baker A.H., Luo Z., Xu Q., Emanueli C. Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation). Pharmacol. Ther. 2011, 129:29-49.
58. Kane N.M., Howard L., Descamps B., Meloni M., McClure J., Lu R., Breen C., Mackenzie R.M., Delles C., Milligan G., Emanueli C., Baker A.H. A role for microRNAs 99b, 181a and 181b in the differentiation to vascular endothelial cells from human embryonic stem cells. Stem Cells 2012, 4:643-654.
59. Kaufman D.S., Hanson E.T., Lewis R.L., Auerbach R., Thomson J.A. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10716-10721.
60. Kazenwadel J., Michael M.Z., Harvey N.L. Prox1 expression is negatively regulated by miR-181 in endothelial cells. Blood 2010, 116:2395-2401.
61. Kim S., von Recum H. Endothelial stem cells and precursors for tissue engineering: cell source, differentiation, selection, and application. Tissue Eng. B Rev. 2008, 14:133-147.
62. Kim K.S., Kim J.S., Lee M.R., Jeong H.S., Kim J. A study of microRNAs in silico and in vivo: emerging regulators of embryonic stem cells. FEBS J. 2009, 276:2140-2149.
63. Kiskinis E., Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Invest. 2010, 120:51-59.
64. Kispert A., Herrmann B.G. Immunohistochemical analysis of the Brachyury protein in wild-type and mutant mouse embryos. Dev. Biol. 1994, 161:179-193.
65. Kitagawa M., Era T. Differentiation of mesodermal cells from pluripotent stem cells. Int. J. Hematol. 2010, 91:373-383.
66. Korin N., Levenberg S. Engineering human embryonic stem cell differentiation. Biotechnol. Genet. Eng. Rev. 2007, 24:243-261.
67. Kraehenbuehl T.P., Ferreira L.S., Hayward A.M., Nahrendorf M., van der Vlies A.J., Vasile E., Weissleder R., Langer R., Hubbell J.A. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 2011, 32:1102-1109.
68. Lagarkova M.A., Volchkov P.Y., Lyakisheva A.V., Philonenko E.S., Kiselev S.L. Diverse epigenetic profile of novel human embryonic stem cell lines. Cell Cycle 2006, 5:416-420.
69. Lagarkova M.A., Volchkov P.Y., Philonenko E.S., Kiselev S.L. Efficient differentiation of hESCs into endothelial cells in vitro is secured by epigenetic changes. Cell Cycle 2008, 7:2929-2935.
70. Lancrin C., Sroczynska P., Stephenson C., Allen T., Kouskoff V., Lacaud G. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 2009, 457:892-895.
71. Larsson E., Fredlund Fuchs P., Heldin J., Barkefors I., Bondjers C., Genove G., Arrondel C., Gerwins P., Kurschat C., Schermer B., et al. Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med. 2009, 1:108.
72. Lasala G.P., Minguell J.J. Vascular disease and stem cell therapies. Br. Med. Bull. 2011, 98:187-197.
73. Lawson K.A., Meneses J.J., Pedersen R.A. Clonal analysis of epiblast fate during germ layer formation in the mouse embryo. Development 1991, 113:891-911.
74. Leeper N.J., Hunter A.L., Cooke J.P. Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation 2010, 122:517-526.
75. Levenberg S., Golub J.S., Amit M., Itskovitz-Eldor J., Langer R. Endothelial cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:4391-4396.
76. Levenberg S., Ferreira L.S., Chen-Konak L., Kraehenbuehl T.P., Langer R. Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells. Nat. Protoc. 2010, 5:1115-1126.
77. Li Z., Wu J.C., Sheikh A.Y., Kraft D., Cao F., Xie X., Patel M., Gambhir S.S., Robbins R.C., Cooke J.P. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 2007, 116:I46-I54.
78. Li Z., Suzuki Y., Huang M., Cao F., Xie X., Connolly A.J., Yang P.C., Wu J.C. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 2008, 26:864-873.
79. Li Z., Han Z., Wu J.C. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases. J. Cell. Biochem. 2009, 106:194-199.
80. Li Z., Wilson K.D., Smith B., Kraft D.L., Jia F., Huang M., Xie X., Robbins R.C., Gambhir S.S., Weissman I.L., et al. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS One 2009, 4:e8443.
81. Lindskog H., Athley E., Larsson E., Lundin S., Hellstrom M., Lindahl P. New insights to vascular smooth muscle cell and pericyte differentiation of mouse embryonic stem cells in vitro. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1457-1464.
82. Lu S.J., Feng Q., Caballero S., Chen Y., Moore M.A., Grant M.B., Lanza R. Generation of functional hemangioblasts from human embryonic stem cells. Nat. Meth. 2007, 4:501-509.
83. Ludwig T.E., Levenstein M.E., Jones J.M., Berggren W.T., Mitchen E.R., Frane J.L., Crandall L.J., Daigh C.A., Conard K.R., Piekarczyk M.S., et al. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 2006, 24:185-187.
84. Margariti A., Xiao Q., Zampetaki A., Zhang Z., Li H., Martin D., Hu Y., Zeng L., Xu Q. Splicing of HDAC7 modulates the SRF-myocardin complex during stem-cell differentiation towards smooth muscle cells. J Cell Sci 2009, 122:460-470.
85. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:7634-7638.
86. Martinez-Estrada O.M., Lettice L.A., Essafi A., Guadix J.A., Slight J., Velecela V., Hall E., Reichmann J., Devenney P.S., Hohenstein P., et al. Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat. Genet. 2010, 42:89-93.
87. Masumura T., Yamamoto K., Shimizu N., Obi S., Ando J. Shear stress increases expression of the arterial endothelial marker ephrinB2 in murine ES cells via the VEGF-Notch signaling pathways. Arterioscler. Thromb. Vasc. Biol. 2009, 29:2125-2131.
88. Miano J.M. Vascular smooth muscle cell differentiation-2010. J Biomed Res 2010, 24(3):169-180.
89. Miano J.M., Cserjesi P., Ligon K.L., Periasamy M., Olson E.N. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ. Res. 1994, 75:803-812.
90. Nakahara M., Nakamura N., Matsuyama S., Yogiashi Y., Yasuda K., Kondo Y., Yuo A., Saeki K. High-efficiency production of subculturable vascular endothelial cells from feeder-free human embryonic stem cells without cell-sorting technique. Cloning Stem Cells 2009, 11:509-522.
91. Nakajima F., Tokunaga K., Nakatsuji N. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells 2007, 25:983-985.
92. Narazaki G., Uosaki H., Teranishi M., Okita K., Kim B., Matsuoka S., Yamanaka S., Yamashita J.K. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008, 118:498-506.
93. Nehls V., Drenckhahn D. The versatility of microvascular pericytes: from mesenchyme to smooth muscle?. Histochemistry 1993, 99:1-12.
94. Nishikawa S., Goldstein R.A., Nierras C.R. The promise of human induced pluripotent stem cells for research and therapy. Nat. Rev. Mol. Cell Biol. 2008, 9:725-729.
95. Nourse M.B., Halpin D.E., Scatena M., Mortisen D.J., Tulloch N.L., Hauch K.D., Torok-Storb B., Ratner B.D., Pabon L., Murry C.E. VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler. Thromb. Vasc. Biol. 2010, 30:80-89.
96. Oberlin E., El Hafny B., Petit-Cocault L., Souyri M. Definitive human and mouse hematopoiesis originates from the embryonic endothelium: a new class of HSCs based on VE-cadherin expression. Int. J. Dev. Biol. 2010, 54:1165-1173.
97. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
98. Oyamada N., Itoh H., Sone M., Yamahara K., Miyashita K., Park K., Taura D., Inuzuka M., Sonoyama T., Tsujimoto H., et al. Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice. J Transl Med 2008, 6:54.
99. Parameswaran M., Tam P.P. Regionalisation of cell fate and morphogenetic movement of the mesoderm during mouse gastrulation. Dev. Genet. 1995, 17:16-28.
100. Pardanaud L., Luton D., Prigent M., Bourcheix L.M., Catala M., Dieterlen-Lievre F. Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. Development 1996, 122:1363-1371.
101. Park S.W., Jun Koh Y., Jeon J., Cho Y.H., Jang M.J., Kang Y., Kim M.J., Choi C., Sook Cho Y., Chung H.M., et al. Efficient differentiation of human pluripotent stem cells into functional CD34+ progenitor cells by combined modulation of the MEK/ERK and BMP4 signaling pathways. Blood 2010, 116:5762-5772.
102. Pepe A.E., Xiao Q., Zampetaki A., Zhang Z., Kobayashi A., Hu Y., Xu Q. Crucial role of nrf3 in smooth muscle cell differentiation from stem cells. Circ. Res. 2010, 106:870-879.
103. Pera M.F., Reubinoff B., Trounson A. Human embryonic stem cells. J Cell Sci 2000, 113(Pt 1):5-10.
104. Poelmann R.E. The formation of the embryonic mesoderm in the early post-implantation mouse embryo. Anat Embryol (Berl) 1981, 162:29-40.
105. Prado-Lopez S., Conesa A., Arminan A., Martinez-Losa M., Escobedo-Lucea C., Gandia C., Tarazona S., Melguizo D., Blesa D., Montaner D., et al. Hypoxia promotes efficient differentiation of human embryonic stem cells to functional endothelium. Stem Cells 2010, 28:407-418.
106. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 2000, 18:399-404.
107. Richards M., Fong C.Y., Chan W.K., Wong P.C., Bongso A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol. 2002, 20:933-936.
108. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
109. Rufaihah A.J., Huang N.F., Jame S., Lee J.C., Nguyen H.N., Byers B., De A., Okogbaa J., Rollins M., Reijo-Pera R., et al. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler. Thromb. Vasc. Biol. 2011, 31:e72-e79.
110. Sakurai H., Era T., Jakt L.M., Okada M., Nakai S., Nishikawa S. In vitro modeling of paraxial and lateral mesoderm differentiation reveals early reversibility. Stem Cells 2006, 24:575-586.
111. Shen G., Tsung H.C., Wu C.F., Liu X.Y., Wang X.Y., Liu W., Cui L., Cao Y.L. Tissue engineering of blood vessels with endothelial cells differentiated from mouse embryonic stem cells. Cell Res 2003, 13:335-341.
112. Shimizu N., Yamamoto K., Obi S., Kumagaya S., Masumura T., Shimano Y., Naruse K., Yamashita J.K., Igarashi T., Ando J. Cyclic strain induces mouse embryonic stem cell differentiation into vascular smooth muscle cells by activating PDGF receptor beta. J. Appl. Physiol. 2008, 104:766-772.
113. Sieveking D.P., Ng M.K. Cell therapies for therapeutic angiogenesis: back to the bench. Vasc Med 2009, 14:153-166.
114. Sims D.E. Diversity within pericytes. Clin. Exp. Pharmacol. Physiol. 2000, 27:842-846.
115. Singla D.K., Hacker T.A., Ma L., Douglas P.S., Sullivan R., Lyons G.E., Kamp T.J. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J. Mol. Cell. Cardiol. 2006, 40:195-200.
116. Sinha S., Hoofnagle M.H., Kingston P.A., McCanna M.E., Owens G.K. Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 2004, 287:C1560-C1568.
117. Sone M., Itoh H., Yamashita J., Yurugi-Kobayashi T., Suzuki Y., Kondo Y., Nonoguchi A., Sawada N., Yamahara K., Miyashita K., et al. Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells. Circulation 2003, 107:2085-2088.
118. Sone M., Itoh H., Yamahara K., Yamashita J.K., Yurugi-Kobayashi T., Nonoguchi A., Suzuki Y., Chao T.H., Sawada N., Fukunaga Y., et al. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2127-2134.
119. Song S., Ewald A.J., Stallcup W., Werb Z., Bergers G. PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 2005, 7:870-879.
120. Subramanyam D., Lamouille S., Judson R.L., Liu J.Y., Bucay N., Derynck R., Blelloch R. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat. Biotechnol. 2011, 29:443-448.
121. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
122. Tam P.P., Beddington R.S. The formation of mesodermal tissues in the mouse embryo during gastrulation and early organogenesis. Development 1987, 99:109-126.
123. Tarnok A., Ulrich H., Bocsi J. Phenotypes of stem cells from diverse origin. Cytometry A 2010, 77:6-10.
124. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
125. Topouzis S., Majesky M.W. Smooth muscle lineage diversity in the chick embryo. Dev. Biol. 1996, 178:430-445.
126. Velican C., Velican D. The precursors of coronary atherosclerotic plaques in subjects up to 40 years old. Atherosclerosis 1980, 37:33-46.
127. Vittet D., Prandini M.H., Berthier R., Schweitzer A., Martin-Sisteron H., Uzan G., Dejana E. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 1996, 88:3424-3431.
128. Vo E., Hanjaya-Putra D., Zha Y., Kusuma S., Gerecht S. Smooth-muscle-like cells derived from human embryonic stem cells support and augment cord-like structures in vitro. Stem Cell Rev 2010, 6:237-247.
129. Vodyanik M.A., Bork J.A., Thomson J.A., Slukvin I.I. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005, 105:617-626.
130. Wang L., Li L., Shojaei F., Levac K., Cerdan C., Menendez P., Martin T., Rouleau A., Bhatia M. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 2004, 21:31-41.
131. Wang Z.Z., Au P., Chen T., Shao Y., Daheron L.M., Bai H., Arzigian M., Fukumura D., Jain R.K., Scadden D.T. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat. Biotechnol. 2007, 25:317-318.
132. Woll P.S., Morris J.K., Painschab M.S., Marcus R.K., Kohn A.D., Biechele T.L., Moon R.T., Kaufman D.S. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood 2008, 111:122-131.
133. Woodcock-Mitchell J., Mitchell J.J., Low R.B., Kieny M., Sengel P., Rubbia L., Skalli O., Jackson B., Gabbiani G. Alpha-smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles. Differentiation 1988, 39:161-166.
134. Xiao Q., Zeng L., Zhang Z., Margariti A., Ali Z.A., Channon K.M., Xu Q., Hu Y. Sca-1+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2244-2251.
135. Xiao Q., Zeng L., Zhang Z., Hu Y., Xu Q. Stem cell-derived Sca-1+ progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin alpha1/beta1/alphav and PDGF receptor pathways. Am J Physiol Cell Physiol 2007, 292:C342-C352.
136. 2. Am J Physiol Cell Physiol 2009, 296:C711-C723.
137. Xie C.Q., Zhang J., Villacorta L., Cui T., Huang H., Chen Y.E. A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells. Arterioscler. Thromb. Vasc. Biol. 2007, 27:e311-e312.
138. Xie C.Q., Huang H., Wei S., Song L.S., Zhang J., Ritchie R.P., Chen L., Zhang M., Chen Y.E. A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells. Stem Cells Dev 2009, 18:741-748.
139. Xie C., Huang H., Sun X., Guo Y., Hamblin M., Ritchie R.P., Garcia-Barrio M.T., Zhang J., Chen Y.E. MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev 2011, 20:205-210.
140. Yamahara K., Sone M., Itoh H., Yamashita J.K., Yurugi-Kobayashi T., Homma K., Chao T.H., Miyashita K., Park K., Oyamada N., et al. Augmentation of neovascularization [corrected] in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS One 2008, 3:e1666.
141. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., Naito M., Nakao K. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000, 408:92-96.
142. Yang C., Zhang Z.H., Li Z.J., Yang R.C., Qian G.Q., Han Z.C. Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb. Haemost. 2004, 91:1202-1212.
143. Zeng L., Xiao Q., Margariti A., Zhang Z., Zampetaki A., Patel S., Capogrossi M.C., Hu Y., Xu Q. HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J. Cell Biol. 2006, 174:1059-1069.
144. Zhang H., Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996, 122:2977-2986.
145. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.
146. Zovein A.C., Hofmann J.J., Lynch M., French W.J., Turlo K.A., Yang Y., Becker M.S., Zanetta L., Dejana E., Gasson J.C., et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 2008, 3:625-636.